Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.

Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.

Item
http://www.wikidata.org/entity/Q36558437
Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant womenPopulation pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations.The effect of UGTs polymorphism on the auto-induction phase II metabolism-mediated pharmacokinetics of dihydroartemisinin in healthy Chinese subjects after oral administration of a fixed combination of dihydroartemisinin-piperaquinePharmacogenomics of antimicrobial agents.The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatmentPharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health TransitionAn optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in CambodiaAssessment of pharmacokinetic compatibility of short acting CDRI candidate trioxane derivative, 99-411, with long acting prescription antimalarials, lumefantrine and piperaquine.MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy.Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.African variation at Cytochrome P450 genes: Evolutionary aspects and the implications for the treatment of infectious diseases.Cytochrome P450 pharmacogenetics in African populations: implications for public health.Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions.A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications.CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients.The drug transporter ABCB1 c.3435C>T SNP influences artemether-lumefantrine treatment outcome.
P2860

Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.

Item
http://www.wikidata.org/entity/Q36558437
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effect of single nucleotide po ...... ts from Cambodia and Tanzania.
@ast
Effect of single nucleotide po ...... ts from Cambodia and Tanzania.
@en
type
label
Effect of single nucleotide po ...... ts from Cambodia and Tanzania.
@ast
Effect of single nucleotide po ...... ts from Cambodia and Tanzania.
@en
prefLabel
Effect of single nucleotide po ...... ts from Cambodia and Tanzania.
@ast
Effect of single nucleotide po ...... ts from Cambodia and Tanzania.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Effect of single nucleotide po ...... ts from Cambodia and Tanzania.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932